Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Yingting Lu, Chunrong Ying, Ligen Liu, Limin Zhao, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Li Yang

Blood (2024) 144 (Supplement 1): 6888.

https://doi.org/10.1182/blood-2024-207982

Published: 2024

Journal Articles

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Limin Zhao, Ligen Liu, Li Yang, Fangli Chen, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Chunrong Ying

Blood (2024) 144 (Supplement 1): 6055.

https://doi.org/10.1182/blood-2024-207516

Published: 2024

Journal Articles

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Fangli Chen, Ligen Liu, Huijie Chen, Yicheng Wu, Yuanqin Wang, Zhen Fu, Tinghua Zhang, Xuewei Jiang, Yingting Lu, Limin Zhao, Jutang Li, Li Yang

Blood (2024) 144 (Supplement 1): 5842.

https://doi.org/10.1182/blood-2024-207505

Published: 2024

Journal Articles

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

Ligen Liu, Yuanmmei Zhai, Li Yang, Limin Zhao, Li Chang, Chunrong Yin, Yingting Lu, Xuewei Jiang, Zhizhi Zhang

Blood (2021) 138 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2021-144631

Published: 2021

Journal Articles

Establishment of TRAIL-Resistance Kasumi-1 Cell Line and the Analysis of It different mRNA Expression Profile with the Original Kasumi-1 Cell Line

Xuewei Jiang, MD, Pan Zengkai, Chen Jin, Yu Pengfei, Li-Gen Liu, MD

Blood (2014) 124 (21): 5221.

https://doi.org/10.1182/blood.V124.21.5221.5221

Published: 2014

NARROW

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

Establishment of TRAIL-Resistance Kasumi-1 Cell Line and the Analysis of It different mRNA Expression Profile with the Original Kasumi-1 Cell Line

Email alerts

ASH Publications

American Society of Hematology

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

Establishment of TRAIL-Resistance Kasumi-1 Cell Line and the Analysis of It different mRNA Expression Profile with the Original Kasumi-1 Cell Line

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only